The Nigeria Infectious Disease In-vitro Diagnostics Market size is projected to reach US$ 59.67 million by 2031 from US$ 41.04 million in 2024. The market is estimated to register a CAGR of 5.5% during 2024–2031. Technological advancements are likely to bring new Nigeria Infectious Disease In-vitro Diagnostics Market trends in the coming years.
Nigeria Infectious Disease In-vitro Diagnostics Market Analysis
The Nigerian in-vitro diagnostics (IVD) market for infectious diseases is expanding due to several key drivers and emerging opportunities. The rising prevalence of infectious diseases, such as Lassa fever, HIV, and malaria, necessitates timely and accurate diagnostic solutions. This demand is further supported by government initiatives like the National Health Insurance Scheme (NHIS), which enhances accessibility to diagnostic services. Technological advancements, particularly in point-of-care testing (POCT) and molecular diagnostics, are pivotal in providing rapid and precise results, crucial for effective disease management in resource-limited settings. Integrating artificial intelligence (AI) and machine learning (ML) into diagnostic processes also revolutionizes data analysis, leading to more accurate and personalized disease detection. These developments present significant opportunities for stakeholders to invest in innovative diagnostic technologies that cater to the growing healthcare needs of Nigeria's population.
Nigeria Infectious Disease In-vitro Diagnostics Market Overview
Key players are focusing on boosting local manufacturing capacity, fostering innovation, and reducing dependency on imported diagnostic products. In May 2025, Codix Pharma Ltd, a Nigerian pharmaceutical firm, commissioned Codix Bio Ltd, an IVD manufacturing facility in Sagamu, Ogun State. This facility, the first in Nigeria and the second in sub-Saharan Africa, is expected to produce over 147 million rapid diagnostic test kits annually for malaria, HIV, and hepatitis B and C. This development addresses the need for timely, affordable, locally produced diagnostics, especially for underserved populations. Such initiatives strengthen healthcare independence, improve disease surveillance, and propel market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Nigeria Infectious Disease In-vitro Diagnostics Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Nigeria Infectious Disease In-vitro Diagnostics Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Nigeria Infectious Disease In-vitro Diagnostics Market Drivers and Opportunities
Increasing Number of Diagnostic Centers
As of May 2025, there are 937 Diagnostic centers in Nigeria, representing a 3.65% increase from 2023. Of these locations, 899 Diagnostic centers, which is 95.94% of all Diagnostic centers in Nigeria, are single-owner operations, while the remaining 38, 4.06%, are part of larger brands. The top three states with the most Diagnostic centers are Lagos, with 256 Diagnostic centers; Federal Capital Territory, with 104 Diagnostic centers; and Enugu State, with 72 Diagnostic centers.
With the rising burden of malaria, HIV, and tuberculosis, the demand for accurate and timely diagnostic services is surging. The increased availability of diagnostic centers, particularly in urban and semi-urban areas, has improved healthcare accessibility and reduced patient turnaround times, thereby boosting the adoption of IVD technologies. Establishing private labs such as 54gene and Lifebank and public initiatives under the Nigeria Centre for Disease Control (NCDC) has increased testing capacity for COVID-19 and Lassa fever. These centers rely on molecular diagnostics, immunoassays, and rapid test kits. Collaborations with international partners have led to capacity-building and technology transfer. Expansion of diagnostic capabilities improves accurate diagnosis, disease monitoring, supporting public health responses, and shaping healthcare policies contribute to market growth.
Government Initiatives To Increase Awareness Regarding Infectious Diseases
Through the Nigerian Center for Disease Control (NCDC) and the Ministry of Health, the government promotes public health campaigns targeting malaria, HIV/AIDS, and tuberculosis. These campaigns emphasize early detection, prevention, and management, encouraging more people to seek diagnostic testing. As awareness grows, healthcare providers and diagnostic centers are adopting advanced IVD technologies to meet the rising demand for reliable and rapid tests. Nationwide HIV screening programs supported by government initiatives have increased the need for efficient in-vitro diagnostic kits.
Partnerships with international health organizations and government subsidies help improve access to these diagnostic tools, especially in rural and underserved areas. This supportive environment attracts investments from diagnostic companies aiming to develop and distribute innovative testing solutions tailored to local needs. By creating sustained demand for diagnostic innovations, government-driven awareness campaigns are expected to create future growth opportunities for the Nigeria infectious disease .
Nigeria Infectious Disease Report Segmentation Analysis
Key segments that contributed to the derivation of the Infectious disease in-vitro diagnostics market analysis are application, end user, and geography.
- Based on application, the Nigeria infectious disease in-vitro diagnostics market is segmented into HIV/AIDS, tuberculosis, hepatitis b & c, malaria, and others. The malaria segment held the largest share of the market in 2024, and it is expected to register a significant CAGR during 2024–2031.
- By end user, the market is divided into hospitals and clinics, diagnostic laboratories, blood banks, and others. Hospitals and clinics held the largest Nigeria infectious disease in-vitro diagnostics market share in 2024.
Nigeria Infectious Disease In-vitro Diagnostics Market Share Analysis by Geography
The Nigeria Infectious Disease In-vitro Diagnostics Marketis expanding steadily, fueled by a high burden of communicable diseases such as HIV/AIDS, malaria, tuberculosis, and hepatitis. With a growing population and increasing demand for early and accurate disease detection, diagnostic technologies, remarkably rapid tests, and point-of-care diagnostics are being adopted. Urban areas are witnessing better penetration due to improved healthcare infrastructure, while rural areas remain underserved but represent significant growth potential. Government health initiatives, international donor funding, and a gradual shift toward localized manufacturing and public-private partnerships support the market. However, challenges such as limited diagnostic labs, stringent regulations, and insufficient skilled personnel persist. Overall, the sector holds strong potential for investment and innovation, particularly in portable and affordable diagnostic solutions.
Nigeria Infectious Disease In-vitro Diagnostics Market Report Scope
Nigeria Infectious Disease In-vitro Diagnostics Market News and Recent Developments
The Nigeria Infectious Disease In-vitro Diagnostics Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are listed below:
- Bruker Corporation announced expansions to its infectious disease testing solutions at the ESCMID Global conference in Vienna, including a broader assay menu for its BeGenius molecular diagnostics system and improvements to its microbial identification platforms. (Source: Bruker Corporation, Company Website, April 2025)
- bioMérieux, a world leader in the field of in vitro diagnostics, announced the launch of its WATCHFIRE molecular testing solution. The WATCHFIRE Respiratory (R) Panel, targeting 22 pathogens*, will run on the BIOFIRE FILMARRAY TORCH instrument, integrated with FIREWORKS™ software, to deliver real-time trending of viruses and bacteria present in wastewater samples. (Source: bioMérieux, Company Website, April 2025).
Nigeria Infectious Disease In-vitro Diagnostics Market Report Coverage and Deliverables
The "Nigeria Infectious Disease In-vitro Diagnostics Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Infectious disease in-vitro diagnostics market size and forecast at country levels for all the key market segments covered under the scope
- Infectious disease in-vitro diagnostics market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Infectious disease in-vitro diagnostics market analysis covering key market trends, country framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Infectious disease in-vitro diagnostics market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The increasing number of diagnostic centers and strategic developments by key players fuel the market growth.
The market value is expected to reach US$ 59.67 million by 2031.
Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, Sysmex Corp, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, QuidelOrtho Corp, Bruker Corp are key players in the market.
Malaria dominated the market in 2024.
Technological advancements are expected to emerge as a prime trend in the market in the coming years.
The market is expected to register a CAGR of 5.5% during 2024–2031.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Hypothesis formulation:
2.2.2 Macro-economic factor analysis:
2.2.3 Developing base number:
2.2.4 Data Triangulation:
2.2.5 Country level data:
2.3 Assumptions and Limitations
3. Nigeria Infectious Disease In-Vitro Diagnostics Market Landscape
3.1 Overview
3.2 PEST Analysis
4. Nigeria Infectious Disease In-Vitro Diagnostics Market – Key Market Dynamics
4.1 Nigeria Infectious Disease In-Vitro Diagnostics Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increase in the Number of Diagnostic Center
4.2.2 Strategic Developments by Key Players
4.3 Market Restraints
4.3.1 Lack of Skilled Laboratory Professionals
4.4 Market Opportunities
4.4.1 Government Initiatives To Increase Awareness Regarding Infectious Diseases
4.5 Future Trends
4.5.1 Technological Advancement
4.6 Impact of Drivers and Restraints:
5. Nigeria Infectious Disease In-Vitro Diagnostics Market Analysis
5.1 Nigeria Infectious Disease In-Vitro Diagnostics Market Revenue (US$ Million), 2021–2031
5.2 Nigeria Infectious Disease In-Vitro Diagnostics Market Forecast and Analysis
6. Nigeria Infectious Disease In-Vitro Diagnostics Market Analysis – by Application
6.1 HIV or AIDS
6.1.1 Overview
6.1.2 HIV or AIDS: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.2 Tuberculosis
6.2.1 Overview
6.2.2 Tuberculosis: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.3 Hepatitis B and C
6.3.1 Overview
6.3.2 Hepatitis B and C: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.4 Malaria
6.4.1 Overview
6.4.2 Malaria: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.5 Others
6.5.1 Overview
6.5.2 Others: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
7. Nigeria Infectious Disease In-Vitro Diagnostics Market Analysis – by End User
7.1 Hospitals and Clinics
7.1.1 Overview
7.1.2 Hospitals and Clinics: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.3 Blood Bank
7.3.1 Overview
7.3.2 Blood Bank: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
8. Competitive Landscape
8.1 Heat Map Analysis by Key Players
8.2 Company Market Share Analysis, 2024
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 F. Hoffmann-La Roche Ltd
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Becton Dickinson and Co
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Sysmex Corp
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.5 bioMerieux SA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Bio-Rad Laboratories Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 QIAGEN NV
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 QuidelOrtho Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Bruker Corp
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
List of Tables
Table 1. Nigeria Infectious Disease In-Vitro Diagnostics Market Segmentation
Table 2. Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue, 2021–2024 (US$ Million)
Table 3. Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 4. Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue, 2021–2024 (US$ Million) – By Application
Table 5. Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue Forecast, 2025–2031 (US$ Million) – By Application
Table 6. Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue, 2021–2024 (US$ Million) – By End User
Table 7. Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue Forecast, 2025–2031 (US$ Million) – By End User
Table 8. Heat Map Analysis by Key Players
Table 9. Recent Organic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
Table 10. Recent Inorganic Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
List of Figures
Figure 1. Nigeria Infectious Disease In-Vitro Diagnostics Market Segmentation
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Nigeria Infectious Disease In-Vitro Diagnostics Market Revenue (US$ Million), 2021–2031
Figure 5. Nigeria Infectious Disease In-Vitro Diagnostics Market Share (%) – by Application, 2024 and 2031
Figure 6. HIV or AIDS: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 7. Tuberculosis: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 8. Hepatitis B and C: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 9. Malaria: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 10. Others: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 11. Nigeria Infectious Disease In-Vitro Diagnostics Market Share (%) – by End User, 2024 and 2031
Figure 12. Hospitals and Clinics: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 13. Diagnostic Laboratories: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 14. Blood Bank: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 15. Others: Nigeria Infectious Disease In-Vitro Diagnostics Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 16. Company Market Share Analysis, 2024
Figure 17. Growth Strategies in the Nigeria Infectious Disease In-Vitro Diagnostics Market
The List of Companies - Nigeria Infectious Disease In-vitro Diagnostics Market
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Becton Dickinson and Co
- Sysmex Corp
- bioMerieux SA
- Bio-Rad Laboratories Inc
- QIAGEN NV
- QuidelOrtho Corp
- Bruker Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Nigeria Infectious Disease In-vitro Diagnostics Market
Jun 2025
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Jun 2025
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Jun 2025
Pediatric Cardiology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Transcatheter Heart Valves, Occlusion Devices, Catheters, Stents, Introducer Sheaths, and Others), Disease Indication (Congenital Heart Disease, Acquired Heart Disease, Arrhythmias, Cardiomyopathies, and Others), Surgical Procedure (Interventional Procedures, Heart Rhythm Management Procedures, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2025
Pharmaceutical Membrane Filters Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Microfiltration, Ultrafiltration, Reverse Osmosis and Nanofiltration), Design (Hollow Fiber, Spiral Wound, Tubular System and Plate and Frame), Material (Polyethersulfone (PES), Polysulfone (PS), Cellulose-Based Membranes, Polytetrafluoroethylene (PTFE), Polyvinyl Chloride (PVC), Polyacrylonitrile (PAN) and Others), End User (Pharmaceutical and Biotech Industries and CROs and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
Jun 2025
ECG Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG and Stress ECG), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2025
Surgical Laser Fiber Units Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (CO2 Laser, Diode Laser, Erbium Laser, Nd:YAG Laser, Holmium Laser, Alexandrite Laser, and Others), Material (Silica-Based Fibers, Quartz Fibers, Polymer-Based Fibers, Multimode Fibers, and Others), Power (Low-Power Lasers, Medium-Power Lasers, and High-Power Lasers), Application (Urology, Dermatology, Gynecology, Cardiology, Neurology, Ophthalmology, Respiratory, Dentistry and Others), Wavelength (9,301 nm and above, 2,941–9,300 nm, and 1,441–2,940 nm, 821–1,440 nm, 710–820 nm, and below 710 nm), End User (Hospitals, Specialty Clinics, Physician Office, and Others), and Geography
Jun 2025
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography
Jun 2025
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography
Get Free Sample For